Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis

Eloseily, Esraa M., Weiser, Peter, Crayne, Courtney B., Haines, Hilary, Mannion, Melissa L., Stoll, Matthew L., Beukelman, Timothy, Atkinson, T. Prescott +1 more·2020·Arthritis & Rheumatology
DOI 10.1002/art.41103

Cited by (281)

Items 101–200 of 281

  1. Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment
    Jin Yong Lee, Kil Seong Bae, Jung Woo Rhim, Soo Young Lee, Dae Chul Jeong, Jin Han Kang · 2024 · Children
  2. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
    Mikhail Kiselevskiy, Irina Zh. Shubina, Irina Olegovna Chikileva, С. М. Ситдикова, Игорь Вячеславович Самойленко, N. Yu. Anisimova, Кирилл Игоревич Киргизов, А М Сулейманова, Tatyana Gorbunova, Светлана Рафаэлевна Варфоломеева · 2020 · Pharmaceuticals
  3. Identification of human immune cell subtypes most responsive to IL-1β–induced inflammatory signaling using mass cytometry
    Hema Kothari, Corey M. Williams, Chantel C. McSkimming, Fabrizio Drago, Melissa A. Marshall, James C. Garmey, Mythili Vigneshwar, Eli R. Zunder, Coleen A. McNamara · 2021 · Science Signaling
  4. COVID-19-associated secondary hemophagocytic lymphohistiocytosis (cytokine storm syndrome)
    Ekaterina I. Alexeeva, Тепаев Рустэм Фаридович, I.Yu. Shilkrot, T.M. Dvoryakovskaya, A.G. Surkov, Криулин Иван Алексеевич · 2021 · Annals of the Russian academy of medical sciences
  5. Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children
    James E. G. Charlesworth, Shaun R Wilson, Amrana Qureshi, Esther Blanco, Amy F. Mitchell, Shelley Segal, Dominic F. Kelly, James Weitz, Deirdre O'Shea, Kathryn M. Bailey et al. · 2021 · Pediatric Blood & Cancer
  6. The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
    Konstantinos G. Kyriakoulis, Αναστάσιος Κόλλιας, Garyphallia Poulakou, Ioannis Kyriakoulis, Ioannis Panagiotis Trontzas, Andriani G. Charpidou, Konstantinos Syrigos · 2021 · Journal of Clinical Medicine
  7. Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome
    Hanfei Guo, Lei Qian, Jiuwei Cui · 2021 · Cancer Biology and Medicine
  8. Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
    Mikhail Mikhaylovich Kostik, Eugenia A. Isupova, Konstantin E. Belozerov, Tatyana Serafimovna Likhacheva, Evgeny N. Suspitsin, Rinat K. Raupov, V.V. Masalova, И. А. Чикова, Margarita Fedorovna Dubko, Olga Valeryevna Kalashnikova et al. · 2022 · Frontiers in Pediatrics
  9. Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity
    Andrea Taddio, Sara Della Paolera, Luisa Abbagnato, Anna Agrusti, Raffaele Badolato, Francesca Biscaro, Roberta Caorsi, Alessandro Consolaro, Rosa Maria Dellepiane, Marianna Fabi et al. · 2023 · Lara D. Veeken
  10. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children
    Hua Pan, Gaoyan Wang, Enben Guan, Liang Song, Aiqin Song, Xiaodan Liu, Zhi Yi, Lirong Sun · 2020 · BMC Pediatrics
  11. Hemoperfusion with CytoSorb to Manage Multiorgan Dysfunction in the Spectrum of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill Children
    Gabriella Bottari, Manuel Murciano, Pietro Merli, Claudia Bracaglia, Isabella Guzzo, Francesca Stoppa, Manuela Pardeo, Joseph Nunziata, Francesca Del Bufalo, Leonardo Genuini et al. · 2021 · Blood Purification
  12. Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis
    Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher · 2022 · International Journal of Molecular Sciences
  13. Anakinra versus etoposide‐based therapy added to high‐dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis
    Benjamin J. Lee, Yen Thi Kim Hong Cao, Pongthep Vittayawacharin, Ghaydá É'Leima, Sherif A. Rezk, Jack Reid, Elizabeth A. Brem, Stefan Octavian Ciurea, Piyanuch Kongtim · 2023 · European Journal Of Haematology
  14. Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study
    Shanmuganathan Chandrakasan, Carl E. Allen, Deepika Bhatla, John Carter, May C. Chien, Robert Cooper, Lauren R. Draper, Olive S. Eckstein, Rabi Hanna, J. Allyson Hays et al. · 2024 · Arthritis & Rheumatology
  15. Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance
    Sofia Ajeganova, Ann De Becker, Rik Schots · 2020 · Therapeutic Advances in Musculoskeletal Disease
  16. Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes
    Ali Abdelhay, Amir A Mahmoud, Mariam Ahmed Osman Mostafa, Tripti Jain, Sheref A. Elseidy, Suhib Fahmawi, Mouaz Alkasem, Omar Ammari · 2023 · Annals of Hematology
  17. Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis–associated refractory macrophage activation syndrome
    Jianqiang Wu, Li Sun, Xuemei Tang, Qi Zheng, Li Guo, Li Nan Xu, Yandie Li, Meiping Lu · 2021 · Modern Rheumatology
  18. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
    Maria L. Taylor, Kacie J. Hoyt, Joseph K. Han, Leslie A. Benson, Siobhan Case, Mia T. Chandler, Margaret H. Chang, Craig D. Platt, Ezra M. Cohen, Megan Day‐Lewis et al. · 2022 · The Journal of Rheumatology
  19. A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm Syndrome
    Daniel D. Reiff, Mingce Zhang, Emily A. Smitherman, Melissa L. Mannion, Matthew Laurence Stoll, Peter Weiser, Randy Quentin Cron · 2022 · Life
  20. High Prevalence of Hemophagocytic Lymphohistiocytosis in Acute Liver Failure of Infancy
    Nedim Hadžić, Emese Ilyésné Molnár, Sue E. Height, Gábor Kovács, Anil Kumar Dhawan, Hajnalka Andrikovics, Austen J. J. Worth, Kimberly C Gilmour · 2022 · The Journal of Pediatrics
  21. Weal and woe of interleukin-18 in the T cell therapy of cancer
    Christoph Kessel, Claudia Rössig, Hinrich Abken · 2025 · Journal for ImmunoTherapy of Cancer
  22. The microbiota-related coinfections in COVID-19 patients: a real challenge
    Ranjan K. Mohapatra, Kuldeep Dhama, Snehasish Mishra, Ashish Kumar Sarangi, Venkataramana Kandi, Ruchi Tiwari, Lucia Pintilie · 2021 · Beni-Suef University Journal of Basic and Applied Sciences
  23. Immunomodulating Phytochemicals: An Insight into their Potential Use in Cytokine Storm Situations.
    Abdusalam Abdullah Alarabei, Nur Aimi Liyana Abd Aziz, Nur Izah Ab Razak, Razif Abas, Hasnah Bahari, Maizaton Atmadini Abdullah, Mohd Khairi Hussain, Amin Malik Shah Abdul Majid, Rusliza Basir · 2023 · Advanced Pharmaceutical Bulletin
  24. Coronavirus Desease 2019 (COVID-19) in Children: Lessons from Pediatric Rheumatology
    Maria I. Kaleda, И. П. Никишина, E. S. Fedorov, Evgeny Lvovich Nasonov · 2020 · Rheumatology Science and Practice
  25. Macrophage Activation Syndrome in Children: Diagnosis and Management
    Narendra Kumar Bagri, Latika Gupta, Ethan S Sen, Athimalaipet Vaidyanathan Ramanan · 2021 · Indian Pediatrics
  26. TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases
    Nahid Aslani, Kosar Asnaashari, Nima Parvaneh, Mohammad Shahrooei, Maryam Sotoudeh-Anvari, Farhad Shahram, Vahid Ziaee · 2022 · Pediatric Rheumatology
  27. Anakinra was not associated with lower mortality in hospitalised COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
    Wenli Shang, Yingying Zhang, Guizuo Wang, Dong Hee Han · 2023 · Reviews in Medical Virology
  28. Management of adverse events in young adults and children with acute B-cell lymphoblastic leukemia receiving anti-CD19 chimeric antigen receptor (CAR) T-cell therapy
    Jae Won Yoo · 2023 · Blood Research
  29. Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolution
    Li Han, Xinran Wu, Ou Wang, Xiao Luan, William H. Velander, Michael C. Aynardi, Eric Scott Halstead, Anthony S. Bonavia, Rong Jin, Guohong Li et al. · 2023 · Theranostics
  30. Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists
    Mai Kawazoe, Mari Kihara, Toshihiro Nanki · 2021 · Pharmaceuticals
  31. Effect of COVID‐19 on anakinra‐induced remission in homozygous STX11 hemophagocytosis lymphohistiocytosis
    Anshul Vagrecha, Hiren B. Patel, Tania Mamdouhi, Suchitra S. Acharya, Abena Appiah‐Kubi, Banu Aygün, Adrianna Vlachos, Lawrence C. Wolfe, Jeffrey Michael M Lipton, Randy Quentin Cron et al. · 2021 · Pediatric Blood & Cancer
  32. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis
    Marci Macaraeg, Grant S. Schulert · 2023 · RMD Open
  33. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
    Natsumi Inoue, Grant S. Schulert · 2023 · Arthritis Research & Therapy
  34. Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
    Šárka Fingerhutová, Eva Jančová, Pavla Doležalová · 2022 · Frontiers in Pediatrics
  35. Interleukin-1–mediated hyperinflammation in XIAP deficiency is associated with defective autophagy
    Dilan Dissanayake, Ashkan Firouzabady, Mohammad Massumi, Guillermo A. de Paz Linares, Christian R. Marshall, Spencer A. Freeman, Ronald M. Laxer, Rae S. M. Yeung · 2024 · Blood
  36. Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications
    Antoine Fakhry AbdelMassih, David Ramzy, Lauren Nathan, Silvia Aziz, Mirette Ashraf, Nourhan Hatem Youssef, Nouran Hafez, Rana Saeed, Hala Mounir Agha · 2020 · Cardiovascular Endocrinology & Metabolism
  37. Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults
    Alexandra Dreyzin, David Alex Jacobsohn, Anne L. Angiolillo, Birte Wistinghausen, Reuven J. Schore, Evelio D. Perez‐Albuerne, Elizabeth Molloy Wells, Joshua Terao, Challice Lee Bonifant, Radha Rohatgi et al. · 2021 · Pediatric Hematology and Oncology
  38. Clinical features of hemophagocytic syndrome following BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
    Cheng Zu, Kexin Wang, Qiqi Zhang, Yongxian Hu, He Huang · 2022 · Journal of Zhejiang University (Medical Sciences)
  39. The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist)
    Evgeny Lvovich Nasonov, Samsonov MIu · 2022 · Rheumatology Science and Practice
  40. To “Lump” or to “Split” in Macrophage Activation Syndrome and Hemophagocytic Lymphohistiocytosis
    Sarah Nikiforow, Nancy Berliner · 2019 · Arthritis & Rheumatology
  41. Investigation of Serum Ferritin for the Prediction of COVID-19 Severity and Mortality: A Cross-Sectional Study
    Jihad M. Hadi, Hawar M Mohammad, Ako Y Ahmed, Shko Sh. Tofiq, Las B Abdalrahman, Awin A Qasm, Ali M Ameer · 2022 · Cureus
  42. Current Options in the Treatment of COVID-19: A Review
    Azadeh Teimury, Elahe Mahmoodi Khaledi · 2020 · Risk Management and Healthcare Policy
  43. Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
    Alessandro Russo, Helen Linda Morrone, Salvatore Rotundo, Enrico Maria Trecarichi, Carlo Torti · 2022 · Diagnostics
  44. Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children
    Randy Quentin Cron · 2022 · Current Opinion in Rheumatology
  45. HLH treatment: smarter, not harder
    Lauren A. Henderson, Barbara A. Degar · 2022 · Blood
  46. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature
    Yong Chang, Xueyan Shan, Yongpeng Ge · 2023 · Pediatric Rheumatology
  47. The latest advances in the use of biological DMARDs to treat Still’s disease
    Ilenia Di Cola, Piero Ruscitti · 2024 · Expert Opinion on Biological Therapy
  48. Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study
    Benjamin J. Lee · 2024 · Therapeutic Advances in Hematology
  49. Kawasaki Disease-Associated Cytokine Storm Syndrome
    Paul Tsoukas, Rae S. M. Yeung · 2024 · Advances in experimental medicine and biology
  50. Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors
    Evgeny Lvovich Nasonov · 2020 · PULMONOLOGIYA
  51. Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case series
    Luke Flower, Nick Laundy, Maryam Khosravi, Jim Buckley, Aislinn Gale, Inder D Kumar, Oluwatomisin Otenigbagbe, Rachel Scarlett Tattersall, Jessica J. Manson, Vanessa Quick · 2021 · The Lancet Rheumatology
  52. The Novel Coronavirus and Inflammation
    Jaya A. George, Elizabeth Sarah Mayne · 2021 · Advances in experimental medicine and biology
  53. Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study
    Laura Scholz, Florian Posch, Eduard Schulz, Max Gornicec, Albert Wölfler, Alexander Christian Reisinger, Andreas Reinisch, Philipp Eller, Florian Eisner, Philipp Kreuzer et al. · 2024 · Critical Care Explorations
  54. Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm
    Lesley E. Jackson, Nitasha Khullar, Timothy Beukelman, Chris Chapleau, Abhishek Kamath, Randy Quentin Cron, Walter Winn Chatham · 2023 · Viruses
  55. Calm before the Storm
    Manuel B. Braga Neto, Andrew D. Badley, Sameer A. Parikh, Rondell P. Graham, Patrick S. Kamath · 2022 · New England Journal of Medicine
  56. Treatment of hemophagocytic lymphohistiocytosis in the era of new biologics
    Kenneth L. McClain · 2020 · Pediatric Blood & Cancer
  57. Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia
    Elizabeth D. Slaney, Renee Modica, Leandra U. Woolnough, Dina Kafisheh, Denise Heather Bell-Brunson, Melissa E. Elder · 2024 · Frontiers in Pediatrics
  58. IL-1 Family Blockade in Cytokine Storm Syndromes
    Randy Quentin Cron · 2024 · Advances in experimental medicine and biology
  59. Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies
    Jingming Wang, Huiwen Jiang, Yinqiang Zhang, Yu Hu, Heng Mei · 2024 · Expert Review of Clinical Immunology
  60. Immunomodulation in Pediatric Sepsis: A Narrative Review
    Gabriella Bottari, Fabio Silvio Taccone, Angelica Corrias, Mariangela Irrera, Paolo Currao, Michele Salvagno, Corrado Cecchetti, Didier M. Payen · 2025 · Journal of Clinical Medicine
  61. Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome
    Rohith Jesudas, Kim E. Nichols · 2022 · Current Opinion in Allergy and Clinical Immunology
  62. CLINICAL UTILITY OF INTERLEUKIN-1 INHIBITORS IN PEDIATRIC SEPSIS
    Ravi Manchikalapati, Jonathon Schening, Andrew J. Farias, Keith A. Sacco · 2023 · Shock
  63. Drs. Cron and Chatham reply
    Randy Quentin Cron, Winn W Chatham · 2020 · The Journal of Rheumatology
  64. Precision medicine in juvenile idiopathic arthritis—has the time arrived?
    Daniel D. Reiff, Matthew Laurence Stoll, Randy Quentin Cron · 2021 · The Lancet Rheumatology
  65. Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature
    Domenico Umberto De Rose, Francesca Campi, Chiara Maddaloni, Sara Ronci, Stefano Caoci, Immacolata Savarese, Iliana Bersani, Maria Paola Ronchetti, Cinzia Auriti, Irma Capolupo et al. · 2025 · Pediatric Drugs
  66. Macrophage activation syndrome in Kawasaki disease: a literature review of Korean studies
    Dae Chul Jeong, Soo Young Lee · 2025 · Journal of Rheumatic Diseases
  67. Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation
    Lauren A. Henderson, Roshini Sarah Abraham, Aisha Siddiqah Ahmed, Lindsey Blount, Scott Canna, Natalia S. Chaimowitz, Shanmuganathan Chandrakasan, Bria M. Coates, James Albert Connelly, Megan A. Cooper et al. · 2025 · Frontiers in Immunology
  68. Early management of hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a systematic literature review
    Dimitri Poddighe, Bita Shakoory, Ashley V. Geerlinks, Marta Wilejto, Kate F. Kernan, Melissa Hines, Micol Romano, David Piskin, Ovgu Kul Cınar, Jonathan Park et al. · 2025 · EULAR Rheumatology Open
  69. Promising Targeted Therapies for Hemophagocytic Lymphohistiocytosis: A Translational Perspective Based on Immunopathology
    Yuanyuan Yang, Songtao Tu, Hongwei Peng, Jialiang Lu, Hua Yu, Yulan Zhou, Xiaowu Dong, Fei Li · 2025 · Clinical Reviews in Allergy & Immunology
  70. DOCK2 Mutation and Recurrent Hemophagocytic Lymphohistiocytosis
    Daniel D. Reiff, Mingce Zhang, Randy Quentin Cron · 2023 · Life
  71. The Trilogy of SARS-CoV-2 in Pediatrics (Part 2): Multisystem Inflammatory Syndrome in Children
    Van L. Tran, Sarah Parsons, Andrew M Nuibe · 2021 · The Journal of Pediatric Pharmacology and Therapeutics
  72. Identification of Key Biomarkers and Immune Infiltration in Systemic Juvenile Idiopathic Arthritis by Integrated Bioinformatic Analysis
    Min Zhang, Rongxin Dai, Qin Zhao, Lina Zhou, Yunfei An, Xuemei Tang, Xiaodong Zhao · 2021 · Frontiers in Molecular Biosciences
  73. NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors
    Farzaneh‐Sadat Rezazadeh‐Shojaee, Esmaeel Azadian, Min Xian Wong, Xiuquan Ma, James A. Rickard, Jiyi Pang, Catherine Hall, Andrew J. Kueh, Seth Lucian Masters, Inmaculada Rioja et al. · 2025 · Science Advances
  74. Secondary haemophagocytic lymphohistiocytosis in a patient with new-onset systemic lupus erythematosus: the challenges of timely diagnosis and successful treatment
    Daming Shao, Oscar Pena, Miroslav Sekulic, Ronald Valdez Imbert, Charan Thej Reddy Vegivinti, Belinda Jim · 2023 · BMJ Case Reports
  75. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) coinfected with COVID-19 complicated by hemophagocytic lymphohistiocytosis: a case report
    Mengmeng Li, Furong li, Yang Dai, Yunou Zhang Zeng, Xiaomei Chen · 2024 · Frontiers in Immunology
  76. Drugs for paediatric hyperinflammatory syndromes
    Kam‐Lun Ellis Hon, Alexander K. C. Leung, Wing Hang Leung, Karen Ka Yan Leung, Kai Ning Cheong, Pamela PW Lee · 2022 · Drugs in Context
  77. Use of Intravenous Anakinra for Management of Pediatric Cytokine Storm Syndromes at an Academic Medical Center
    Lirong Yang, Sandra Lowry, Travis S. Heath · 2023 · Hospital Pharmacy
  78. Postpartum fevers, a rare presentation of secondary hemophagocytic lymphohistiocytosis
    Jacqueline Lee, Brian Pham, Zarir E. Karanjawala, Oyebimpe Adesina · 2023 · Clinical Case Reports
  79. Distinct roles of IL-18 and IL-1β in murine model of macrophage activation syndrome
    Mao Mizuta, Natsumi Inoue, Masaki Shimizu, Naoto Sakumura, Tadafumi Yokoyama, Rie Kuroda, Yasuhiro Ikawa, Naotoshi Sugimoto, Kenichi Harada, Akihiro Yachie et al. · 2023 · Journal of Allergy and Clinical Immunology
  80. Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature
    Aleksandra Opaliñska, Dominika Kwiatkowska, Adrian Burdacki, Mirosław Markiewicz, Dominik Samotij, Marek Dudziński, Jadwiga Niemiec-Dudek, Elżbieta Ostańska, Adam Reich · 2021 · Dermatology and Therapy
  81. The diagnostic importance of multiple cytokines in adult hemophagocytic lymphohistiocytosis
    Zhili Jin, Dina Suolitiken, Yini Wang, Zhao Wang · 2022 · Journal of Clinical Laboratory Analysis
  82. An unforeseen reality: Hemophagocytic lymphohistiocytosis following alemtuzumab treatment for a multiple sclerosis
    Anka Blagotinšek Ošep, Eva Brecl, Matevž Škerget, Lina Savšek · 2023 · Clinical Neurology and Neurosurgery
  83. Successful treatment of severe COVID-19 pneumonia, a case series with simultaneous interleukin-1 and interleukin-6 blockade with 1-month follow-up
    Hildrun Haibel, Denis Poddubnyy, Stefan Angermair, Kristina Allers, Janis Lucas Vahldiek, Michael Schümann, Thomas Schneider · 2022 · Therapeutic Advances in Musculoskeletal Disease
  84. Acute kidney injury in critical care: complications of hemophagocytic lymphohistiocytosis
    Mengya Zhao, Yiming Guan, Jin Lin, Yu Qiu, Shen Zhao, Meili Duan · 2024 · Frontiers in Immunology
  85. Cytokine Storm Syndromes Associated with Epstein–Barr Virus
    Katherine Verbist, Kim E. Nichols · 2024 · Advances in experimental medicine and biology
  86. Macrophage Activation Syndrome
    Sonia Iosim, Lauren A. Henderson · 2025 · Hematology/Oncology Clinics of North America
  87. Therapeutic options for the management of severe COVID-19: A rheumatology perspective
    Claudia Mendoza Pinto, Mario García‐Carrasco, Pamela Munguía‐Realpozo, Socorro Méndez‐Martínez · 2020 · Reumatología Clínica (English Edition)
  88. Treatment Strategies for Central Nervous System Effects in Primary and Secondary Haemophagocytic Lymphohistiocytosis in Children
    Samantha Cooray, Saraswathy Sabanathan, Yael Hacohen, Austen J. J. Worth, Despina Eleftheriou, Cheryl A Hemingway · 2022 · Current Treatment Options in Neurology
  89. Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still’s disease/systemic lupus erythematosus: insights from nine cases
    Jie Chen, Liling Zhao, Yanwei Lin, Xinyue Lian, Haiting Wang, Liyang Gu, Ran Wang, Xiaodong Wang, Shuang Ye, Qiong Fu · 2025 · Frontiers in Immunology
  90. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases
    Shuoyin Huang, Yingying Liu, Wu Yan, Tonghao Zhang, Panpan Wang, Meifang Zhu, Xiaohua Zhang, Peng Zhou, Zhidan Fan, Haiguo Yu · 2024 · Pediatric Rheumatology
  91. Advancing multidisciplinary management of pediatric hyperinflammatory disorders
    Francesco La Torre, Giovanni Meliota, Adele Civino, Angelo Campanozzi, Valerio Cecinati, Enrico Rosati, Emanuela Sacco, Nicola Santoro, Ugo Vairo, Fabio Cardinale · 2025 · Frontiers in Pediatrics
  92. Juvenile Idiopathic Arthritis
    Randy Quentin Cron, Sangeeta Sule, Jordan T. Jones, Tristan Kerr, Kimberly A. Morishita, Ross E. Petty, Carol B. Lindsley · 2023 · Springer eBooks
  93. Central Nervous System Hemophagocytic Lymphohistiocytosis (CNS-HLH) from Leptomeningeal Anaplastic Large Cell Lymphoma
    Helaina Lehrer, Eileen Scigliano, Amy Chan · 2021 · Clinical Neuroradiology
  94. Atypical Presentation of Systemic Arthritis in a Toddler with Down Syndrome
    Emily Worley, Weijie Li, Jordan T. Jones · 2021 · Case Reports in Pediatrics
  95. Hemophagocytic Lymphohistiocytosis for the Internist and Other Primary Care Providers
    Tanmayi Pai, Fernando F. Stancampiano, Candido E. Rivera · 2021 · Journal of Primary Care & Community Health
  96. The Big Bad Wolf: Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus
    Grant S. Schulert · 2022 · The Journal of Rheumatology
  97. Cytokine Storm Syndrome Triggered by Extracorporeal Membrane Oxygenation in Pediatric Patients
    Daniel D. Reiff, Randy Quentin Cron · 2023 · Children
  98. Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting
    Holly Wobma, Lauren A. Henderson, Christine Duncan, Susan E. Prockop, Adrienne G. Randolph, Barbara A. Degar, Leslie Lehmann, Susanne H.C. Baumeister · 2025 · Frontiers in Oncology
  99. Hemophagocytic Lymphohistiocytosis (HLH) Following Immune Checkpoint Therapy (ICT)
    Saivaroon Gajagowni, Emily Wang, Jianbo Wang, Matthew T. Campbell, Bilal Ahmed Siddiqui · 2025 · Case Reports in Oncological Medicine
  100. Molecular Mechanisms and Pathophysiology of Myocardial Disease: Insights from Pediatric Inflammatory Multisystem Syndrome (PIMS) Associated with SARS-CoV-2
    María Teresa Viadero, María Jesús Caldeiro, Natalia Fernández Suárez, Jesús Garde, María Jesús Cabero, Domingo González‐Lamuño · 2025 · International Journal of Molecular Sciences